Endocrine Abstracts

Background: Lonapegsomatropin (SKYTROFA™; TransCon hGH), an FDA and EMA approved once-weekly prodrug of somatropin for pediatric growth hormone deficiency (pGHD), uses TransCon® technology to transiently link an inert carrier to a parent drug to achieve sustained release. Daily growth hormone injection, standard treatment for pGHD for decades, may be associated with challenges including needle anxiety and low adherence. The lonapegsomatropin Auto-Injector, winner of ...

Background: Minimally invasive parathyroidectomy (MIP) is usually performed with the concurrent use of intraoperative adjuncts for good outcome.Objective: We wanted to show that a good success rate can be achieved in MIP without routine use of any intraoperative adjuncts.Methods: A prospective case series of the first 100 patients who underwent MIP for primary hyperparathyroidism by a single surgeon at a single institution were inc...